Inbox Robot: Merck & Co. News http://www.inboxrobot.com/news/merckConstantly updated news and information about a variety of topics. Gilead, Bradmer Launch Pivotal Programs in HIV, Brain Cancer http://www.inboxrobot.com/news.php?fid=179975711 24 Jul 2008 02:51 GMT ... clear marketing advantage over the existing twice-daily integrase inhibitor marketed by Whitehouse Station, N.J.-based Merck & Co. Inc. as ... To continue reading the complete article, login or register ... Statin Study Could Yield Gene Variant Test http://www.inboxrobot.com/news.php?fid=179965323 24 Jul 2008 00:56 GMT ... genetic analyses drew from two previous large studies that were in part funded by Merck & Co., which makes the one-time cholesterol blockbuster, Zocor, now available as the low-cost ... Test Offers Hope in Combatting Cholesterol Drug Side Effects http://www.inboxrobot.com/news.php?fid=179964271 24 Jul 2008 00:55 GMT ... genetic analyses drew from two previous large studies that were in part funded by Merck & Co., which makes the one-time cholesterol blockbuster, Zocor, now available as the low-cost ... Take Templeton's advice and buy when the mood is gloomy http://www.inboxrobot.com/news.php?fid=179954424 23 Jul 2008 23:18 GMT ... such software companies as Oracle Corp. and Microsoft Corp., and drug stocks such as Merck & Co. or U.K.-based GlaxoSmithKline PLC. The $3.4-billion fund is only 3% in cash, ... Statins may help kidney transplant patients: study http://www.inboxrobot.com/news.php?fid=179950182 23 Jul 2008 22:51 GMT ... the risk of death from influenza, pneumonia and Some statins include Pfizer Inc's Lipitor, Merck & Co's Zocor, AstraZeneca's Crestor and Bristol-Myers Squibb Co's Pravachol. The study was backed ... Vytorin makers say cancer results likely an anomaly http://www.inboxrobot.com/news.php?fid=179950181 23 Jul 2008 22:51 GMT ... drug Vytorin are "likely to be an anomaly" unrelated to the drug, makers Merck & Co and Schering-Plough Corp said in a letter to doctors. The study, called ... Gene may help ID statin side effect risk http://www.inboxrobot.com/news.php?fid=179949636 23 Jul 2008 22:32 GMT ... genetic analyses drew from two previous large studies that were in part funded by Merck & Co., which makes the one-time cholesterol blockbuster, Zocor, now available as the low-cost ... Statin study could lead to test for gene variant http://www.inboxrobot.com/news.php?fid=179948251 23 Jul 2008 22:30 GMT ... genetic analyses drew from two previous large studies that were in part funded by Merck & Co., which makes the one-time cholesterol blockbuster, Zocor, now available as the low-cost ... Weak dollar, foreign sales boost drugmakers http://www.inboxrobot.com/news.php?fid=179947940 23 Jul 2008 22:30 GMT ... the last two weeks. Favorable currency exchange rates boosted revenue by 5 percent for Merck & Co. and by 7.6 percent for Schering-Plough Corp. Schering also noted that about ... New HIV Drug Shows Viral Load Reduction in Treatment-Resistant Patients http://www.inboxrobot.com/news.php?fid=179943535 23 Jul 2008 21:54 GMT ... were enrolled in North and South America. Both of these studies are supported by Merck & Co, Inc., the manufacturer of raltegravir. According to Co-investigator David Cooper, M.D., D.Sc., ... Statins may help kidney transplant patients: study http://www.inboxrobot.com/news.php?fid=179943340 23 Jul 2008 21:54 GMT ... the risk of death from influenza, pneumonia and Some statins include Pfizer Inc's Lipitor, Merck & Co's Zocor, AstraZeneca's Crestor and Bristol-Myers Squibb Co's Pravachol. The study was backed ... Vytorin makers say cancer results likely an anomaly http://www.inboxrobot.com/news.php?fid=179943338 23 Jul 2008 21:54 GMT ... drug Vytorin are "likely to be an anomaly" unrelated to the drug, makers Merck & Co and Schering-Plough Corp said in a letter to doctors. The study, called ... Weak dollar, foreign sales boost drugmakers http://www.inboxrobot.com/news.php?fid=179940304 23 Jul 2008 21:32 GMT ... the last two weeks. Favorable currency exchange rates boosted revenue by 5 percent for Merck & Co. and by 7.6 percent for Schering-Plough Corp. Schering also noted that about ... Statin study could lead to test for gene variation linked to rare drug side effect http://www.inboxrobot.com/news.php?fid=179939871 23 Jul 2008 21:32 GMT ... genetic analyses drew from two previous large studies that were in part funded by Merck & Co., which makes the one-time cholesterol blockbuster, Zocor, now available as the low-cost ... Merck and Schering-Plough prepare Vytorin letter http://www.inboxrobot.com/news.php?fid=179939821 23 Jul 2008 21:31 GMT ... NEW YORK - Vytorin partners Merck & Co. and Schering-Plough Corp. have prepared a letter for physicians who might be ...